Under construction – not a live service
Sign in
Taking people in MexicoNo phase

Tests a support program for adults with type 2 diabetes

Tests a short education program with remote support for type 2 diabetes.

Plain-language title generated from the registry record
Registry title: Validation of an Integrated Attention Model for Patients With Type 2 Diabetes

Key facts

Where
Mexico City, MexicoSee the site

AI summary: who the study is looking for

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with type 2 diabetes diagnosed in the last five years, who have family support and no disabling diabetes complications.

Age
Over 18 and under 70 years old.
Sex
All sexes can join.
Disease stage
Type 2 diabetes diagnosed in the five previous years, free of disabling diabetes complications.

Main reasons for not taking part

  • Advanced diabetes complications, such as ischemic heart disease, heart failure NYHA III-IV, KDOQI ≥3 renal failure, amputations, cerebral vascular disease, gastroparesis or muscular atrophy
  • Type 1 diabetes, gestational diabetes, or diabetes linked to genetic syndromes, or hyperlabile diabetes
  • Other illnesses that limit life expectancy, such as malignant tumors
  • Advanced cognitive impairment or serious psychiatric disorders
  • Smoking, alcoholism or illegal drug dependence

Read by machine on 12 November 2026.

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Source: NCT02836808, who can take part

Where in Mexico

  • Instituto Nacional de Ciencias Medicas y NutricionMexico City, MexicoContact: Carlos A Aguilar-Salinas, MDTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Trial details

Who runs it
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Trial code
NCT02836808
Record updated
6 March 2018
Original description
Abstract: Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores.Read full original descriptionShow less

Validation of an Integrated Attention Model for Patients With Type 2 Diabetes

Abstract: Empowerment interventions for chronic diseases are an evolving process. No agreement exists regarding the necessary components and methodologies to be applied. Systematic reviews have assessed the effect of self-management interventions. Improvements in illness beliefs, adherence to drug therapy and glucose monitoring have been reported. In the long term, no major changes have been achieved in weight, physical activity, smoking status, and depression scores.

There is a need for additional studies. The Center for Comprehensive Care of Patients with Diabetes (CAIPaDi) program is an intervention designed to provide education and empowerment techniques (using simple low-cost interactive tools) over a short period of time followed by at-distance support using internet or cell phone technology. The target population consists of patients with type 2 diabetes, free of chronic complications who are non-smokers. The intervention is composed of four monthly visits followed by a continuous at-distance support system. At each visit, patients stay for six hours in the center. Information is presented in group sessions. Empowerment techniques are applied during individual exchanges with the team or during facilitated group sessions. In summary, empowerment programs are an unmet need in many healthcare services.

Inclusion: being over 18 and under 70 years old; having diagnosis of type 2 diabetes in the five previous years,; having family support; free of disabling diabetes complications.

Exclusion: smoking, alcoholism or illegal drug dependence; advanced complications of diabetes, such as ischemic heart disease, heart failure NYHA III-IV, KDOQI ≥3 renal failure, amputations, cerebral vascular disease, gastroparesis and muscular atrophy ; type 1 diabetes mellitus, gestational diabetes or some variant of diabetes related to genetic syndromes, hyperlabile diabetes; co-morbidities that limit their life expectancy such as malignant tumors; advanced cognitive impairment or serious psychiatric disorders; conditions that require surgical treatment in the short run or which prevent moderated activity.

ClinicalTrials.gov NCT02836808